Virtual hospitals are driving a transformative shift in the healthcare landscape by alleviating demand on traditional hospital resources while offering greater accessibility of care that extends far beyond the hospital walls. Powered by continuous advancements in sensor technology and artificial intelligence (AI), virtual hospital setups encompass a diverse range of applications, propelling a rapidly expanding global market. These digital healthcare platforms facilitate a pivotal transition from the conventional hospital-centric model to decentralized, community-based, and home-based care models. By empowering patients to actively manage their health and facilitating the design of proactive, tailored treatment plans, virtual hospitals redefine the way healthcare is conceptualized and delivered. These platforms not only offer seamless remote monitoring of vital signs and health parameters but also encourage individuals to become proactive participants in their health journey. Virtual hospitals ensure that healthcare becomes more accessible, efficient, and data-informed, thereby revolutionizing the trajectory of medical care provision.
Join us for this virtual BioBridge workshop which brings together an expert panel from across Australia and New Zealand covering topics such as telemonitoring for COVID-19 survivors, skin-like sensing devices for real time diagnosis, indigenous community technology development, and orthopaedic remote monitoring.
Register here
Speakers:
Daymon Nin. As Principal Consultant Daymon is a member of the executive team at WhÄnau Tahi, and leads the design and implementation of systems for Iwi, Urban MÄori, and other indigenous groups internationally. He brings culturally involved design thinking for technology, people, and practices, as well as expertise in Maori Data Sovereignty and Governance practice. He has advised organisations and indigenous groups in Australia, USA, South-East Asia, Africa, and the UK. Daymonās background has also included scaled ERP system implementations, solution architecture, outcome measurement, and organization change. Daymon has also been recognised for his work in the advancement of MÄori Enterprise.
Professor Josephine Chow. Josephine is the foundation Professor, Southwestern Sydney (SWS) Nursing and Midwifery Research Alliance and Ingham Institute for Applied Medical Research, providing mentoring and advice to emerging research leaders and equipping them to lead their own teams on large studies. She is also the Deputy Director of Research, SWS Local Health District (LHD) providing strategic direction on research for the organisations. She held the Director Strategy and Partnership for SWSLHD for over 10 years with research ethics, governance and development in her portfolio and she managed a team of staff in supporting a large number of research, innovations, major contracts/tenders and model of care redesign. She is the Honorary Professor, University of New South Wales, Western Sydney University and the University of Sydney. She completed her PhD, and Master of Business Administration. She has a strong track record with successful collaborative partnerships with global industries.
Associate Professor Andrew McDaid. Founder of OPUM Technologies and Associate Professor at the University of Aucklandās Faculty of Engineering. OPUM Technologies is a medical device and data company focused on delivering knee health analytics to patients and the orthopaedic market with an AI-powered wearable, remote-patient monitoring platform. Associate Professor McDaid will discuss the research and development behind OPUM Technologiesā device.
Professor Wenlong Cheng. Wenlong is professor and director of research in the Department of Chemical and Biological Engineering at Monash University. He is currently NHMRC Investigator Leadership Fellow and a fellow of Ryal Society and was also an Ambassador Tech Fellow in Melbourne Centre for Nanofabrication. He earned his PhD from Chinese Academy of Sciences in 2005 and his BS fom Jilin University, China in 1999. He was Alexander von Humboldt fellow in the Max Planck Institute of Microstructure Physics and a research associate in the Department of Biological and Environmental Engineering of Cornell University. He founded Monash NanoBionics lab at the Monash University in 2010. His research interest lies at the Nano-Bio Interface, particularly self-assembly of 2D plasmonic nanomaterials, DNA nanotechnology, electronic skins and stretchable energy devices. He has published >200 papers. He is currently the scientific editor for Nanoscale Horizon (Royal Society of Chemistry) and the editorial board members for a few journals including Nanoscale, Nanoscale Horizons, Nanoscale Advances, Advanced Sensor Research, Advanced Electronic Materials, ChemNanomat, Advanced Sensors and Energy Materials, iScience, Chemosensors, and Austin Journal of Biomedical Engineering.